• Ownership

Jonathan G. Drachman - Insider Trading & Ownership

Entity
Individual
Location
21823 30 Th Drive Se, Bothell, WA
Summary
The estimated net worth of Jonathan G. Drachman is at least $1.7M dollars as of March 11, 2024. Jonathan G. Drachman is the President and CEO, Director of Neoleukin Therapeutics, Inc. and owns shares of Neurogene Inc. (NGNE) stock worth about $1.59M. Jonathan G. Drachman is the Director of Calithera Biosciences, Inc. and owns shares of Calithera Biosciences, Inc. (CALA) stock worth about $77.2K. Jonathan G. Drachman is the Director of Harpoon Therapeutics, Inc. and owns shares of Harpoon Therapeutics, Inc. stock worth about $32.2K.
All Insider Reports
All Insider Reports

Ownership of Jonathan G. Drachman

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NGNE Neurogene Inc. President and CEO, Director $1.59M Aug 2, 2022
CALA Calithera Biosciences, Inc. Director $77.2K Nov 10, 2021
HARP Harpoon Therapeutics, Inc. Director $32.2K Mar 8, 2024

Insider Transactions Reported by Jonathan G. Drachman:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.